FUJIFILM Diosynth Biotechnologies Plans Gene Therapy Innovation Center in College Station, Texas

URLhttps://www.areadevelopment.com/newsItems/11-26-20
SourceArea Development
Date Published11/26/2019
Author NameArea Development News Desk
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name FUJIFILM Diosynth Biotechnologies
Parent companyFUJIFILM Holdings Corporation
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):100
Year reshoring announced:2019
Year reshoring implemented or to be implemented:2021
Capital investment ($):120
Country(ies) from which reshored:Japan
City reshored to:College Station
State(s) reshored to:TX
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredgene therapies
What domestic positive factors made reshoring more attractive?Automation/technology, Eco-system synergies, Other, expansion
Find Reshoring Articles